Primary |
Product Used For Unknown Indication |
36.7% |
Drug Use For Unknown Indication |
16.0% |
Gastrooesophageal Reflux Disease |
9.3% |
Dyspepsia |
6.0% |
Anxiety |
3.3% |
Prophylaxis Against Gastrointestinal Ulcer |
3.3% |
Abdominal Pain |
2.7% |
Abdominal Pain Upper |
2.0% |
Gastric Resection |
2.0% |
Helicobacter Infection |
2.0% |
Hiatus Hernia |
2.0% |
Hypertension |
2.0% |
Immunosuppression |
2.0% |
Prophylaxis |
2.0% |
Urinary Tract Infection |
2.0% |
Acid Reflux (Oesophageal) |
1.3% |
Back Pain |
1.3% |
Epigastric Ache |
1.3% |
Gastritis |
1.3% |
Oesophageal Reflux |
1.3% |
|
Hypomagnesaemia |
21.5% |
Vomiting |
10.8% |
Tubulointerstitial Nephritis |
7.7% |
Paraesthesia |
6.2% |
Tetany |
4.6% |
Toxicity To Various Agents |
4.6% |
Urinary Incontinence |
4.6% |
Dysarthria |
3.1% |
Gastrointestinal Disorder |
3.1% |
Maternal Drugs Affecting Foetus |
3.1% |
Maternal Exposure During Pregnancy |
3.1% |
Mobility Decreased |
3.1% |
Mouth Ulceration |
3.1% |
Muscle Spasms |
3.1% |
Muscular Weakness |
3.1% |
Myositis |
3.1% |
Nausea |
3.1% |
Pain |
3.1% |
Swollen Tongue |
3.1% |
Thrombocytopenia |
3.1% |
|
Secondary |
Product Used For Unknown Indication |
61.0% |
Hypertension |
6.4% |
Depression |
4.0% |
Plasma Cell Myeloma |
3.2% |
Drug Use For Unknown Indication |
2.8% |
Gastrooesophageal Reflux Disease |
2.8% |
Helicobacter Pylori Infection |
2.0% |
Anxiety |
1.6% |
Cardiac Disorder |
1.6% |
Gastroesophageal Reflux |
1.6% |
Pain |
1.6% |
Prophylaxis |
1.6% |
Urinary Tract Infection |
1.6% |
Anaesthesia |
1.2% |
Cardiac Failure Congestive |
1.2% |
Diabetes Mellitus |
1.2% |
Parkinson's Disease |
1.2% |
Suicide Attempt |
1.2% |
Type 1 Diabetes Mellitus |
1.2% |
Type 2 Diabetes Mellitus |
1.2% |
|
Toxicity To Various Agents |
11.8% |
Vomiting |
11.8% |
Tremor |
8.8% |
Premature Baby |
5.9% |
Rash |
5.9% |
Single Functional Kidney |
5.9% |
Syncope |
5.9% |
Vision Blurred |
5.9% |
White Blood Cell Count Decreased |
5.9% |
Cardiac Failure |
2.9% |
Cardiac Procedure Complication |
2.9% |
Dizziness |
2.9% |
Drug Interaction |
2.9% |
Drug Prescribing Error |
2.9% |
Dyspnoea |
2.9% |
Fatigue |
2.9% |
Foetal Malformation |
2.9% |
Gastrooesophageal Reflux Disease |
2.9% |
Hepatomegaly |
2.9% |
Hypovitaminosis |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
25.0% |
Plasma Cell Myeloma |
21.0% |
Multiple Sclerosis |
6.5% |
Depression |
6.3% |
Hypertension |
6.1% |
Hepatitis C |
4.6% |
Osteoporosis |
3.7% |
Chronic Myeloid Leukaemia |
3.6% |
Prostate Cancer Metastatic |
3.4% |
Drug Use For Unknown Indication |
2.4% |
Type 2 Diabetes Mellitus |
2.4% |
Diffuse Large B-cell Lymphoma |
2.2% |
Gait Disturbance |
2.0% |
Hodgkin's Disease |
1.9% |
Hypercholesterolaemia |
1.7% |
Pain |
1.7% |
Bladder Disorder |
1.5% |
Breast Cancer |
1.5% |
Analgesic Therapy |
1.2% |
Colorectal Cancer Metastatic |
1.2% |
|
Vomiting |
15.9% |
Renal Failure Acute |
7.3% |
White Blood Cell Count Decreased |
6.9% |
Weight Decreased |
6.5% |
Urinary Tract Infection |
6.0% |
Nausea |
5.6% |
Platelet Count Decreased |
5.2% |
Syncope |
5.2% |
Pneumonia |
4.3% |
Thrombocytopenia |
4.3% |
Tremor |
4.3% |
Paraesthesia |
3.9% |
Pyrexia |
3.9% |
Rash Pruritic |
3.4% |
Fatigue |
3.0% |
Pruritus |
3.0% |
Vision Blurred |
3.0% |
White Blood Cell Count Increased |
3.0% |
Off Label Use |
2.6% |
Palpitations |
2.6% |
|